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None of this should stop, however, since the 
explosion of knowledge on putative molecu-
lar mechanisms of dementia has inspired an 
increasing number of possible avenues for 
translational applications, that may continue 
to yield palliative strategies, and possibly 
prevention, even in the absence of a more 
coherent  conceptual  scheme  to  integrate 
levels of medical and scientific inquiry span-
ning from the molecule all the way to the 
entire organism. Frontiers in Dementia will 
thus be a forum for the communication and 
exchange of ideas that continue exploiting 
the considerable advantages of Molecular 
Medicine  (a  “Bottom  Up”  approach),  at 
the same time that it fosters the search for 
avenues in Integrative Neuroscience and the 
Generative Sciences that seeks to develop a 
much-needed “Top Down” model to tackle 
Dementia  together  —  and  in  harmony 
— with the comparatively well developed 
“Bottom Up” model.
The search for a viable integrative — 
theoretical and experimental — model is 
probably the main, and yet essentially unrec-
ognized, cause of the Innovation Gap that 
afflicts the entire field of dementia among 
other  challenges  in  cognition,  behavior 
and  consciousness.  The  Innovation  Gap 
(IG) in Dementia is a complex set of chal-
lenges that includes the failure of models 
of  genetically-caused Alzheimer’s  disease 
(AD) lesions and other models of demen-
tia to prove as useful as hoped in the testing 
of innovative treatments, the reduction in 
the number of newly developed medica-
tions for Alzheimer’s disease (AD) despite 
the increasing number of resources spent 
in their development, and the apparent fail-
ure of many recently tested agents for AD 
(Geerts, 2009; Sigurdsson, 2010). While it 
is clear that the latter are among the more 
numerous reasons contributing to the IG, it 
has not been recognized to the same extent 
that the IG is due mainly to the relatively 
crude extrapolation of mainly Molecular 
Level hypotheses — and actual molecular 
discoveries — in the field of dementia to 
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Dementia is widely recognized as a major, 
rapidly  escalating,  epidemic  world-wide 
challenge to the global health care system. 
In  fact,  Alzheimer’s  Disease  International 
(ADI; 2009) estimates that there are over 35 
million people with dementia today world-
wide. Since the numbers of patients with this 
condition nearly double every 20 years, it is 
predicted that there will be about 66 million 
in 2030, and 115 million in 2050. This is true 
not only in wealthy nations, but ADI esti-
mates that 58% of the people with dementia 
live in low and middle income countries. As 
the population in these countries continues 
to age, as in the rest of the world, it is expected 
that their proportion of patients will grow 
to 71% by 2050, whereas the research on 
conditions causing dementia is overwhelm-
ingly done in high-income countries. Thus, 
the  balance  of  disease  burden  is  shifting, 
the burden of research is uneven, and yet, 
according  to  the  ADI, “…The  quality  of 
many studies was relatively poor, although 
it is steadily improving.”
The  impact  of  dementia  is  staggering 
regardless of the aspect measured. For exam-
ple, the annual economic cost of dementia 
has been estimated at U.S. $315 billion (ADI, 
2009). Seventy-two percent of these costs 
arise from high income countries that have 
only 38% of the patients. However, the cost 
for caring that is mostly “indirect” (i.e. infor-
mally provided by family members or indi-
viduals hired outside the health care system) 
nowadays, especially in low income countries, 
but  will  become  increasingly “direct”  (i.e 
placed in the hands of institutions) and thus 
impact their national budgets increasingly. 
There is — of course — no unanimously 
accepted measure of the suffering caused to 
patients and families, whereas the still imper-
fect means to make financial estimates of the 
cost of dementia continue to improve. These, 
as well as numerous additional, converging 
statistics, support ADI’s proposal that “The 
World Health Organization (WHO) should 
declare dementia a world health priority” 
(ADI, 2009).
Compounding this staggering   challenge, 
the cause of most of the most common 
forms  of  dementia,  starting  with  AD, 
remains unknown (Jellinger 2009; Kuljiš, 
2009a). Furthermore, the leading hypoth-
esis about its pathogenesis — the amyloid 
hypothesis — has been questioned for many 
years and is of late under revision due to the 
failure of several treatments based on this 
concept (Geerts, 2009). Similar challenges 
are  experienced  across  the  board  in  the 
entire field, necessitating a re-thinking of 
basic conceptual tenets all the way through 
specific translational applications to diag-
nosis, treatment and eventual prevention.
Frontiers in Dementia aims at contrib-
uting decisively to this challenge by serv-
ing an essential, mostly unaddressed role 
in the global fight against dementia. While 
there is fortunately an increased awareness 
of the challenges posed by dementia, and 
agencies such as ADI have been mobilizing 
for many years to improve still inadequate 
governmental and private resources for the 
care of demented patients and their families, 
conquering these conditions by applications 
of modern biomedicine remains hampered 
by the lack of a unifying scheme for their 
understanding and treatment (Kuljiš, 2009a). 
This should not be surprising, since it is only 
part of the most tangible consequences of 
the lack of a viable framework for under-
standing human behavior and cognition as 
an emergent property of the brain (Kuljiš, 
2010). As a result, most attempts to unravel 
the causes of dementia — and by extension 
the design of useful treatments and pre-
vention — depend on a rather simplistic, 
if still somewhat useful model of the brain 
as a “sick machine” that arose in the 18th 
Century (La Mettrie, 1748), that has been 
successful by exploring increasingly “atom-
izing” reductionist models, in the absence of 
an equally successful scheme that allows the 
wealth of molecular-level observations to be 
integrated through increasingly   higher-scale 
levels of organization all the way up to the 
individual patient (Kuljiš, 2009a,b, 2010). Kuljiš  Grand challenges in dementia 2010
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(Kuljiš, 2009b), passing through molecular, 
  neuropsychological  and  clinical  research 
levels  of  inquiry,  among  many  others. 
Frontiers in Dementia will thus become not 
only a significant contributor to the most 
common approaches in the fight against 
dementia, but will actually help push the 
boundaries of the field in directions that 
are both promising but seriously neglected, 
and that need to be developed urgently in 
order to conquer Alzheimer’s disease and 
related disorders.
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higher levels such as neuronal networks and 
the behavior of the organism (Kuljiš, 2009a). 
In fact, molecular approaches necessitate as 
much reductionism as possible to achieve 
the utmost rigurosity, and therefore have 
tended to neglect key aspects of dementia 
that include the remarkable selectivity for 
specific neurons, neuronal networks and 
even regions of the brain (Kuljiš, 2009b). 
While this should not be ever interpreted 
as indicating that the former approaches 
are not useful, the state of the field clearly 
indicates a need for true integration and 
collaboration across disciplinary borders. 
Since this unmet need is often given merely 
lip service, we intend Frontiers in Dementia 
to provide not only a forum, but an increas-
ingly powerful demonstration and incentive 
for such integration.
In keeping with the goals and philoso-
phy of the Frontiers Organization, we will 
also promote a wide range of contributions 
to the field of dementia, ranging from the 
much-needed array of hypotheses on patho-
genesis  and  pathophysiology  (Fernández 
et al., 2008) to Systems-Level approaches 